Literature DB >> 32111796

The Role of Neutrophil-to-lymphocyte Ratio on the Effect of CRT for Patients With Rectal Cancer.

Daichi Ishikawa1, Masaaki Nishi2, Chie Takasu2, Hideya Kashihara2, Takuya Tokunaga2, Jun Higashijima2, Kozo Yoshikawa2, Mitsuo Shimada2.   

Abstract

BACKGROUND/AIM: Neutrophil-to-lymphocyte ratio (NLR) is an indicator of systemic inflammation and could be a predictive factor in malignant tumors. The aim of this study was to investigate the impact of NLR in patients with lower rectal cancer who received preoperative chemo-radiotherapy (CRT). PATIENTS AND METHODS: Forty-eight patients with lower rectal cancer who underwent preoperative CRT and curative resection were enrolled. Blood samples were obtained before and after CRT. The relationship of NLR with clinical outcome was investigated.
RESULTS: Post-CRT NLR was higher compared to pre-CRT NLR. The patients with higher post-CRT NLR tended to have worse pathological response to CRT compared to those with low post-CRT NLR. The patients with high post-CRT NLR showed poorer 5-year overall survival and 3-year disease free survival while there was no correlation according to pre-CRT NLR. The univariate analysis showed that post-CRT stage and post-CRT NLR were associated with a poorer 5-year overall survival.
CONCLUSION: NLR after preoperative CRT could be a potential prognostic indicator for patients with lower rectal cancer. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  NLR; Rectal cancer; neutrophil-to-lymphocyte ratio; preoperative chemoradiotherapy

Mesh:

Substances:

Year:  2020        PMID: 32111796      PMCID: PMC7157857          DOI: 10.21873/invivo.11850

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  35 in total

1.  Preoperative versus postoperative chemoradiotherapy for rectal cancer.

Authors:  Rolf Sauer; Heinz Becker; Werner Hohenberger; Claus Rödel; Christian Wittekind; Rainer Fietkau; Peter Martus; Jörg Tschmelitsch; Eva Hager; Clemens F Hess; Johann-H Karstens; Torsten Liersch; Heinz Schmidberger; Rudolf Raab
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

2.  Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.

Authors:  Jean-François Bosset; Gilles Calais; Laurent Mineur; Philippe Maingon; Suzana Stojanovic-Rundic; René-Jean Bensadoun; Etienne Bardet; Alexander Beny; Jean-Claude Ollier; Michel Bolla; Dominique Marchal; Jean-Luc Van Laethem; Vincent Klein; Jordi Giralt; Pierre Clavère; Christoph Glanzmann; Patrice Cellier; Laurence Collette
Journal:  Lancet Oncol       Date:  2014-01-17       Impact factor: 41.316

3.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

Review 4.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

5.  Prediction of response to preoperative chemoradiotherapy and establishment of individualized therapy in advanced rectal cancer.

Authors:  Toshihiro Nakao; Takashi Iwata; Masanori Hotchi; Kozo Yoshikawa; Jun Higashijima; Masaaki Nishi; Chie Takasu; Shohei Eto; Hiroki Teraoku; Mitsuo Shimada
Journal:  Oncol Rep       Date:  2015-08-10       Impact factor: 3.906

Review 6.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

7.  Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.

Authors:  Andre Konski; Tianyu Li; Elin Sigurdson; Steven J Cohen; William Small; Stewart Spies; Jian Q Yu; Andrew Wahl; Steven Stryker; Neal J Meropol
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-10       Impact factor: 7.038

8.  Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer.

Authors:  Joji Kitayama; Koji Yasuda; Kazushige Kawai; Eiji Sunami; Hirokazu Nagawa
Journal:  BMC Cancer       Date:  2011-02-10       Impact factor: 4.430

9.  Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism.

Authors:  Hironori Kitade; Takeo Shimasaki; Saya Igarashi; Hiroshi Sakuma; Mitsue Mori; Naohisa Tomosugi; Masuo Nakai
Journal:  Oncol Lett       Date:  2014-02-18       Impact factor: 2.967

10.  Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma.

Authors:  O Dalpiaz; M Pichler; S Mannweiler; J M Martín Hernández; T Stojakovic; K Pummer; R Zigeuner; G C Hutterer
Journal:  Br J Cancer       Date:  2014-04-01       Impact factor: 7.640

View more
  4 in total

1.  Meta-Analysis on the Neutrophil-Lymphocyte Ratio in Rectal Cancer Treated With Preoperative Chemoradiotherapy: Prognostic Value of Pre- and Post-Chemoradiotherapy Neutrophil-Lymphocyte Ratio.

Authors:  Soo Jin Lee; Kyubo Kim; Hae Jin Park
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

2.  Pretreatment blood biomarkers combined with magnetic resonance imaging predict responses to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Authors:  Xinyu Shi; Min Zhao; Bo Shi; Guoliang Chen; Huihui Yao; Junjie Chen; Daiwei Wan; Wen Gu; Songbing He
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

3.  Histopathological and Haemogram Features Correlate with Prognosis in Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation without Pathological Complete Response.

Authors:  Yu-Ming Huang; Hsi-Hsien Hsu; Chien-Kuo Liu; Ching-Kuo Yang; Po-Li Tsai; Tzu-Yin Tang; Shih-Ming Hsu; Yu-Jen Chen
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

4.  Lymphocyte to C-reactive protein ratio predicts long-term outcomes for patients with lower rectal cancer.

Authors:  Masaaki Nishi; Mistuo Shimada; Takuya Tokunaga; Jun Higashijima; Kozo Yoshikawa; Hideya Kashihara; Chie Takasu; Daichi Ishikawa; Yuma Wada; Shohei Eto; Toshiaki Yoshimoto
Journal:  World J Surg Oncol       Date:  2021-07-06       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.